@article{8f1e670829774473b34fe7893ded7072,
title = "A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: Trial IND.186",
author = "Macdonald, {David A.} and Assouline, {Sarit E.} and Joseph Brandwein and Suzanne Kamel-Reid and Eisenhauer, {Elizabeth A.} and Stephen Couban and Stephen Caplan and Alison Foo and Wendy Walsh and Brian Leber",
note = "Funding Information: This trial was supported in part by the Canadian Cancer Society Research Institute core grant to the NCIC Clinical Trials Group and by a research grant from Bayer Inc., Toronto, Canada.",
year = "2013",
month = apr,
doi = "10.3109/10428194.2012.737917",
language = "English",
volume = "54",
pages = "760--766",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "4",
}
